Alpine Associates Management’s Meridian Bioscience Inc VIVO Stock Holding History

Alpine Associates Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-114,800	Closed	-$3.81M	–	53
2022 Q4	$3.81M	Buy	+114,800	New	+$3.7M	0.17%	37

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Alpine Associates Management's VIVO Position: Q1 2023 in Review

Alpine Associates Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 114,800 shares — an estimated $3.81M sold.

Alpine Associates Management first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $3.81M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Alpine Associates Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Alpine Associates Management sold 114,800 Meridian Bioscience Inc shares in Q1 2023, an estimated $3.81M.
Alpine Associates Management first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
Alpine Associates Management's Meridian Bioscience Inc position peaked at $3.81M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Alpine Associates Management's 13F filing for Q1 2023, filed 10 May 2023.